$ICCC
IMMUCELL CORP /DE/ Stock $iccc

$iccc Overview Financials Valuation SEC Filings Company Website

2014 Q2 Form 10-Q Financial Statement

#000114420414030195 Filed on May 14, 2014

Income Statement

Concept	2014 Q2	2014 Q1	2013 Q4
Revenue	$1.540M	$2.082M	$1.559M
YoY Change	12.7%	12.73%	9.73%
Cost Of Revenue	$660.0K	$931.9K	$950.0K
YoY Change	13.24%	17.49%	41.79%
Gross Profit	$880.0K	$1.150M	$607.6K
YoY Change	12.29%	9.14%	-19.0%
Gross Profit Margin	57.14%	55.24%	38.97%
Selling, General & Admin	$580.0K	$543.1K	$490.0K
YoY Change	18.83%	17.96%	-2.0%
% of Gross Profit	65.91%	47.23%	80.64%
Research & Development	$760.0K	$594.2K	$325.0K
YoY Change	179.56%	122.99%	38.71%
% of Gross Profit	86.36%	51.68%	53.49%
Depreciation & Amortization	$120.0K	$112.4K	$120.0K
YoY Change	20.0%	15.69%	20.0%
% of Gross Profit	13.64%	9.77%	19.75%
Operating Expenses	$1.340M	$1.137M	$325.0K
YoY Change	76.33%	56.46%	38.71%
Operating Profit	-$460.0K	$12.56K	-$210.0K
YoY Change	-2039.13%	-96.15%	-1780.2%
Interest Expense	-$10.00K		-$10.00K
YoY Change	0.0%		0.0%
% of Operating Profit
Other Income/Expense, Net	-$10.00K	-$11.41K	-$30.00K
YoY Change	-24.55%	-125.91%	200.0%
Pretax Income	-$470.0K	$1.154K	-$250.0K
YoY Change	-4589.45%	-99.69%	2400.0%
Income Tax	-$180.0K	$14.49K	-$100.0K
% Of Pretax Income		1255.55%
Net Earnings	-$290.0K	-$13.34K	-$150.7K
YoY Change	-4594.73%	-106.53%	793.74%
Net Earnings / Revenue	-18.83%	-0.64%	-9.67%
Basic Earnings Per Share		$0.00	-$0.05
Diluted Earnings Per Share	-$95.71K	$0.00	-$0.05
COMMON SHARES
Basic Shares Outstanding	3.027M shares	3.027M shares
Diluted Shares Outstanding		3.027M shares

Balance Sheet

Concept	2014 Q2	2014 Q1	2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.690M	$4.980M	$5.260M
YoY Change	-17.43%	-6.21%	7.13%
Cash & Equivalents	$1.700M	$2.240M	$2.270M
Short-Term Investments	$2.990M	$2.740M	$2.990M
Other Short-Term Assets	$250.0K	$170.0K	$180.0K
YoY Change	31.58%	-15.0%	-5.26%
Inventory	$940.0K	$947.3K	$1.207M
Prepaid Expenses		$158.1K	$159.1K
Receivables	$430.0K	$720.0K	$631.4K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$6.310M	$6.811M	$7.268M
YoY Change	-21.13%	-11.2%	-1.3%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.590M	$2.649M	$2.525M
YoY Change	15.6%	16.19%	7.09%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$500.0K	$500.0K
YoY Change
Other Assets	$1.380M	$12.92K	$13.64K
YoY Change	2108.14%	-98.9%	-78.57%
Total Long-Term Assets	$4.460M	$4.305M	$3.693M
YoY Change	32.18%	25.14%	0.71%
TOTAL ASSETS
Total Short-Term Assets	$6.310M	$6.811M	$7.268M
Total Long-Term Assets	$4.460M	$4.305M	$3.693M
Total Assets	$10.77M	$11.12M	$10.96M
YoY Change	-5.32%	0.05%	-0.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$150.0K	$366.0K	$152.2K
YoY Change	-12.51%	115.3%	-33.47%
Accrued Expenses	$460.0K	$283.0K	$293.1K
YoY Change	60.97%	23.04%	14.68%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$190.0K	$190.0K	$190.0K
YoY Change	0.0%	5.56%	5.56%
Total Short-Term Liabilities	$830.0K	$841.7K	$635.6K
YoY Change	-7.07%	45.12%	-4.53%
LONG-TERM LIABILITIES
Long-Term Debt	$800.0K	$850.0K	$900.0K
YoY Change	-19.19%	-18.27%	-17.43%
Other Long-Term Liabilities	$40.00K	$40.00K	$30.00K
YoY Change	0.0%	-42.86%	-62.5%
Total Long-Term Liabilities	$840.0K	$890.0K	$930.0K
YoY Change	-18.45%	-19.82%	-20.51%
TOTAL LIABILITIES
Total Short-Term Liabilities	$830.0K	$841.7K	$635.6K
Total Long-Term Liabilities	$840.0K	$890.0K	$930.0K
Total Liabilities	$1.660M	$1.724M	$1.565M
YoY Change	-13.94%	1.42%	-14.76%
SHAREHOLDERS EQUITY
Retained Earnings		-$420.7K	-$407.4K
YoY Change			-22.37%
Common Stock		$10.35M	$10.34M
YoY Change			0.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$512.2K	$514.3K
YoY Change			-2.89%
Treasury Stock Shares			235.1K shares
Shareholders Equity	$9.100M	$9.392M	$9.396M
YoY Change
Total Liabilities & Shareholders Equity	$10.77M	$11.12M	$10.96M
YoY Change	-5.32%	0.05%	-0.63%

Cashflow Statement

Concept	2014 Q2	2014 Q1	2013 Q4
OPERATING ACTIVITIES
Net Income	-$290.0K	-$13.34K	-$150.7K
YoY Change	-4594.73%	-106.53%	793.74%
Depreciation, Depletion And Amortization	$120.0K	$112.4K	$120.0K
YoY Change	20.0%	15.69%	20.0%
Cash From Operating Activities	$30.00K	$304.8K	$90.00K
YoY Change	-93.88%	-31.54%	-43.75%
INVESTING ACTIVITIES
Capital Expenditures	-$270.0K	$44.85K	-$480.0K
YoY Change	285.71%	401.21%	1500.0%
Acquisitions
YoY Change
Other Investing Activities	-$250.0K	-$250.0K	-$250.0K
YoY Change	0.0%	-66.67%	-125.0%
Cash From Investing Activities	-$520.0K	-$291.9K	-$720.0K
YoY Change	57.58%	-61.29%	-174.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-50.00K	-$43.64K	-20.00K
YoY Change	0.0%	-2.22%	-50.0%
NET CHANGE
Cash From Operating Activities	30.00K	$304.8K	90.00K
Cash From Investing Activities	-520.0K	-$291.9K	-720.0K
Cash From Financing Activities	-50.00K	-$43.64K	-20.00K
Net Change In Cash	-540.0K	-$30.65K	-650.0K
YoY Change	-590.91%	-91.32%	-159.63%
FREE CASH FLOW
Cash From Operating Activities	$30.00K	$304.8K	$90.00K
Capital Expenditures	-$270.0K	$44.85K	-$480.0K
Free Cash Flow	$300.0K	$260.0K	$570.0K
YoY Change	-46.43%	-40.42%	200.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	1154681	USD
CY2014Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	12916	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13636	USD
CY2014Q1	us-gaap	Assets Assets	11115797	USD
CY2013Q4	us-gaap	Assets Assets	10960714	USD
CY2014Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	282988	USD
CY2014Q1	us-gaap	Treasury Stock Value TreasuryStockValue	512153	USD
CY2013Q4	us-gaap	Treasury Stock Value TreasuryStockValue	514341	USD
CY2014Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-21244	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-19836	USD
CY2014Q1	us-gaap	Stockholders Equity StockholdersEquity	9391634	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	9395869	USD
CY2014Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11115797	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10960714	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	293076	USD
CY2014Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	366007	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	152153	USD
CY2014Q1	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent	192680	USD
CY2013Q4	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent	190390	USD
CY2014Q1	us-gaap	Liabilities Current LiabilitiesCurrent	841675	USD
CY2014Q1	us-gaap	Common Stock Value CommonStockValue	326115	USD
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	8000000	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3261148	shares
CY2013Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	235114	shares
CY2013Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	159117	USD
CY2014Q1	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	9976	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	15212	USD
CY2014Q1	us-gaap	Assets Current AssetsCurrent	6811147	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	326115	USD
CY2014Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	10019659	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	10011339	USD
CY2014Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-420743	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-407408	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	7267632	USD
CY2014Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2649119	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2524765	USD
CY2014Q1	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	1146615	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	635619	USD
CY2014Q1	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	847144	USD
CY2013Q4	us-gaap	Long Term Loans From Bank LongTermLoansFromBank	896224	USD
CY2014Q1	iccc	Interest Rate Swap InterestRateSwap	35344	USD
CY2013Q4	iccc	Interest Rate Swap InterestRateSwap	33002	USD
CY2014Q1	us-gaap	Long Term Debt LongTermDebt	882488	USD
CY2013Q4	us-gaap	Long Term Debt LongTermDebt	929226	USD
CY2014Q1	us-gaap	Liabilities Liabilities	1724163	USD
CY2013Q4	us-gaap	Liabilities Liabilities	1564845	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2239731	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2270385	USD
CY2014Q1	us-gaap	Short Term Investments ShortTermInvestments	2736000	USD
CY2013Q4	us-gaap	Short Term Investments ShortTermInvestments	2985000	USD
CY2014Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	720026	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	631410	USD
CY2014Q1	us-gaap	Inventory Net InventoryNet	947325	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	1206508	USD
CY2014Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	158089	USD
CY2013Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	5255385	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-30654	USD
CY2014Q1	iccc	Increase Decrease In Short Term Investments IncreaseDecreaseInShortTermInvestments	-249000	USD
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2014Q1	iccc	Increase Decrease In Cash And Cash Equivalents And Short Term Investments IncreaseDecreaseInCashAndCashEquivalentsAndShortTermInvestments	-279654	USD
CY2014Q1	iccc	Cash Fdic Insured Amount Limit CashFdicInsuredAmountLimit	250000	USD
CY2014Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	317881	USD
CY2013Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	270355	USD
CY2014Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	580939	USD
CY2013Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	783060	USD
CY2014Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	48505	USD
CY2013Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	153093	USD
CY2014Q1	iccc	Increase Decrease In Raw Materials Inventories IncreaseDecreaseInRawMaterialsInventories	47526	USD
CY2014Q1	iccc	Increase Decrease In Work In Process Inventories IncreaseDecreaseInWorkInProcessInventories	-202121	USD
CY2014Q1	iccc	Increase Decrease In Finished Goods Inventories IncreaseDecreaseInFinishedGoodsInventories	-104588	USD
CY2014Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-259183	USD
CY2014Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	3184421	USD
CY2013Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	3182686	USD
CY2014Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	2960189	USD
CY2013Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	2940239	USD
CY2014Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	378419	USD
CY2013Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	354243	USD
CY2014Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	194449	USD
CY2013Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	9600	USD
CY2014Q1	us-gaap	Land Land	50000	USD
CY2013Q4	us-gaap	Land Land	50000	USD
CY2014Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6767478	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6536768	USD
CY2014Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4118359	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4012003	USD
CY2014Q1	iccc	Long Term Debt And Bank Debt Current LongTermDebtAndBankDebtCurrent	143614	USD
CY2014Q1	iccc	Long Term Debt And Bank Debt Current Maturities Repayments Of Principal In Next Twelve Months LongTermDebtAndBankDebtCurrentMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	150290	USD
CY2014Q1	iccc	Long Term Debt And Bank Debt Current Maturities Repayments Of Principal In Year Two LongTermDebtAndBankDebtCurrentMaturitiesRepaymentsOfPrincipalInYearTwo	57384	USD
CY2014Q1	iccc	Long Term Debt And Bank Debt Current Maturities Repayments Of Principal In Year Three LongTermDebtAndBankDebtCurrentMaturitiesRepaymentsOfPrincipalInYearThree	61056	USD
CY2014Q1	iccc	Long Term Debt And Bank Debt Current Maturities Repayments Of Principal In Year Four LongTermDebtAndBankDebtCurrentMaturitiesRepaymentsOfPrincipalInYearFour	64876	USD
CY2014Q1	iccc	Long Term Debt And Bank Debt Current Maturities Repayments Of Principal In Year Five LongTermDebtAndBankDebtCurrentMaturitiesRepaymentsOfPrincipalInYearFive	68908	USD
CY2014Q1	iccc	Long Term Debt And Bank Debt Current Maturities Repayments Of Principal After Year Five LongTermDebtAndBankDebtCurrentMaturitiesRepaymentsOfPrincipalAfterYearFive	493696	USD
CY2014Q1	iccc	Total Liabilities Debt Current Portion And Long Term Portion TotalLiabilitiesDebtCurrentPortionAndLongTermPortion	1039824	USD
CY2010Q3	us-gaap	Secured Debt SecuredDebt	2100000	USD
CY2011Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	600000	USD
CY2013Q1	us-gaap	Royalty Income Nonoperating RoyaltyIncomeNonoperating	-3000	USD
CY2014Q1	us-gaap	Royalty Income Nonoperating RoyaltyIncomeNonoperating	0	USD
CY2013Q1	us-gaap	Interest Income Other InterestIncomeOther	2890	USD
CY2014Q1	us-gaap	Interest Income Other InterestIncomeOther	3954	USD
CY2013Q1	us-gaap	Interest Expense Other InterestExpenseOther	17222	USD
CY2014Q1	us-gaap	Interest Expense Other InterestExpenseOther	14962	USD
CY2013Q1	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	61364	USD
CY2014Q1	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	-399	USD
CY2013Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	44032	USD
CY2014Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11407	USD
CY2013Q1	us-gaap	Share Based Compensation ShareBasedCompensation	8381	USD
CY2014Q1	us-gaap	Share Based Compensation ShareBasedCompensation	7358	USD
CY2013Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	1846734	USD
CY2014Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2081752	USD
CY2013Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	793167	USD
CY2014Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	931857	USD
CY2013Q1	us-gaap	Gross Profit GrossProfit	1053567	USD
CY2014Q1	us-gaap	Gross Profit GrossProfit	1149895	USD
CY2013Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	266479	USD
CY2014Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	594209	USD
CY2013Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	221408	USD
CY2014Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	285305	USD
CY2013Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	239014	USD
CY2014Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	257820	USD
CY2013Q1	us-gaap	Operating Expenses OperatingExpenses	726901	USD
CY2014Q1	us-gaap	Operating Expenses OperatingExpenses	1137334	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	326666	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	12561	USD
CY2013Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	-44032	USD
CY2014Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	11407	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	370698	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1154	USD
CY2013Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	166388	USD
CY2014Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14489	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	204310	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	-13335	USD
CY2013Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3019034	shares
CY2014Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3026901	shares
CY2013Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3083546	shares
CY2014Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3026901	shares
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2014Q1	iccc	Initial Purchase Price Per Share Of Common Stock InitialPurchasePricePerShareOfCommonStock	70.00
CY2005Q2	iccc	Rights Expiration Date RightsExpirationDate	2008-09-19
CY2008Q2	iccc	Rights Expiration Date RightsExpirationDate	2011-09-19
CY2011Q3	iccc	Rights Expiration Date RightsExpirationDate	2014-09-19
CY2014Q1	iccc	Rights Exercisable Period Description RightsExercisablePeriodDescription	The Rights (as amended) become exercisable and transferable apart from the common stock upon the earlier of i) 10 days following a public announcement that a person or group (Acquiring Person) has, without the prior consent of the Continuing Directors (as such term is defined in the Rights Agreement), acquired beneficial ownership of 20% or more of the outstanding common stock or ii) 10 days following commencement of a tender offer or exchange offer the consummation of which would result in ownership by a person or group of 20% or more of the outstanding common stock (the earlier of such dates being called the Distribution Date).
CY2008Q2	iccc	Minimum Ownership Threshold Limit MinimumOwnershipThresholdLimit	0.15	pure
CY2011Q3	iccc	Minimum Ownership Threshold Limit MinimumOwnershipThresholdLimit	0.18	pure
CY2008Q2	iccc	Maximum Ownership Threshold Limit MaximumOwnershipThresholdLimit	0.18	pure
CY2011Q3	iccc	Maximum Ownership Threshold Limit MaximumOwnershipThresholdLimit	0.2	pure
CY2014Q1	iccc	Common Stock Rights Redemption Price Description CommonStockRightsRedemptionPriceDescription	Company may redeem the then outstanding Rights in whole, but not in part, at a price of $0.005 per Right, subject to adjustment.
CY2013Q1	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	104528	USD
CY2014Q1	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	125768	USD
CY2014Q1	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	51064	USD
CY2013Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	31445	USD
CY2013Q1	iccc	Interest Rate Swap Before Taxes InterestRateSwapBeforeTaxes	9666	USD
CY2014Q1	iccc	Interest Rate Swap Before Taxes InterestRateSwapBeforeTaxes	-2342	USD
CY2013Q1	iccc	Income Tax Applicable To Interest Rate Swap IncomeTaxApplicableToInterestRateSwap	-3856	USD
CY2014Q1	iccc	Income Tax Applicable To Interest Rate Swap IncomeTaxApplicableToInterestRateSwap	934	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	5810	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1408	USD
CY2013Q1	iccc	Total Comprehensive Income Loss TotalComprehensiveIncomeLoss	210120	USD
CY2014Q1	iccc	Total Comprehensive Income Loss TotalComprehensiveIncomeLoss	-14743	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	9194683	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	5810	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1408	USD
CY2014Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3150	USD
CY2013Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8381	USD
CY2014Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7358	USD
CY2013Q1	us-gaap	Stockholders Equity StockholdersEquity	9413184	USD
CY2013Q1	us-gaap	Depreciation Depreciation	97123	USD
CY2014Q1	us-gaap	Depreciation Depreciation	112362	USD
CY2013Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	719	USD
CY2014Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	719	USD
CY2013Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	166389	USD
CY2014Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	14236	USD
CY2013Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-37	USD
CY2014Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	USD
CY2013Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	101539	USD
CY2014Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	88616	USD
CY2013Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-206025	USD
CY2013Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	44666	USD
CY2014Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1028	USD
CY2013Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-22969	USD
CY2014Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-10088	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-68510	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	21992	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	445300	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	304839	USD
CY2013Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8949	USD
CY2014Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	44853	USD
CY2013Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	500000	USD
CY2014Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	1494000	USD
CY2013Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	1245000	USD
CY2014Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	1245000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-753949	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-291853	USD
CY2013Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	44633	USD
CY2014Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	46790	USD
CY2013Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2014Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	-191862	USD
CY2013Q1	us-gaap	Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1 IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1	5810	USD
CY2014Q1	us-gaap	Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1 IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1	-1408	USD
CY2014Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3150	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-44633	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-43640	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-353282	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2673719	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2320437	USD
CY2013Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2014Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	-252	USD
CY2013Q1	us-gaap	Interest Paid InterestPaid	-17327	USD
CY2014Q1	us-gaap	Interest Paid InterestPaid	-15175	USD
CY2013Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	-8357	USD
CY2014Q1	dei	Document Type DocumentType	10-Q
CY2014Q1	dei	Amendment Flag AmendmentFlag	false
CY2014Q1	dei	Document Period End Date DocumentPeriodEndDate	2014-03-31
CY2014Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2014Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2014Q1	dei	Trading Symbol TradingSymbol	ICCC
CY2014Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3027034	shares
CY2014Q1	dei	Entity Registrant Name EntityRegistrantName	IMMUCELL CORP /DE/
CY2014Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000811641
CY2014Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2014Q1	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2014Q1	us-gaap	Long Term Investments LongTermInvestments	496000	USD
CY2013Q4	us-gaap	Long Term Investments LongTermInvestments	0	USD
CY2013Q1	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	0	USD
CY2014Q1	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	496000	USD
CY2014Q1	iccc	Cash And Cash Equivalents Short Term And Long Term Investments CashAndCashEquivalentsShortTermAndLongTermInvestments	5471731	USD
CY2013Q4	iccc	Cash And Cash Equivalents Short Term And Long Term Investments CashAndCashEquivalentsShortTermAndLongTermInvestments	5255385	USD
CY2013Q1	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	2697	USD
CY2014Q1	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	4405	USD
CY2014Q1	us-gaap	Purchase Obligation PurchaseObligation	379000	USD
CY2014Q1	us-gaap	Property Plant And Equipment Gross Period Increase Decrease PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease	230710	USD
CY2014Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease	106356	USD
CY2014Q1	iccc	Property Plant And Equipmentnet Period Increase Decrease PropertyPlantAndEquipmentnetPeriodIncreaseDecrease	124354	USD
CY2014Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	715369	USD
CY2013Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	609638	USD
CY2013	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	13952	USD
CY2014Q1	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	14201	USD
CY2014Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	701168	USD
CY2013Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	595686	USD
CY2014Q1	us-gaap	Other Receivables OtherReceivables	18810	USD
CY2013Q4	us-gaap	Other Receivables OtherReceivables	35676	USD
CY2014Q1	us-gaap	Income Tax Receivable IncomeTaxReceivable	48	USD
CY2013Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	48	USD
CY2014Q1	iccc	Increase Decrease In Accounts Receivable Gross IncreaseDecreaseInAccountsReceivableGross	105731	USD
CY2014Q1	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	-249	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	105482	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-16866	USD
CY2014Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	0	USD
CY2014Q1	us-gaap	Nature Of Operations NatureOfOperations	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px; font-size-adjust: none; font-stretch: normal" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="TEXT-ALIGN: left; WIDTH: 0.5in"> <div><b>1.</b></div> </td> <td style="TEXT-ALIGN: justify"> <div><b>BUSINESS OPERATIONS</b></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b> </b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> ImmuCell Corporation (the Company) is a growing animal health company whose purpose is to create scientifically-proven and practical products that improve animal health and productivity in the dairy and beef industries. The Company has developed products that provide significant, immediate immunity to newly born dairy and beef cattle. The Company has also developed products that address mastitis, the most significant cause of economic loss to the dairy industry.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013Q1	iccc	Derivatives Interest Rate Swap Payments DerivativesInterestRateSwapPayments	5781	USD
CY2014Q1	iccc	Derivatives Interest Rate Swap Payments DerivativesInterestRateSwapPayments	5566	USD
CY2014Q1	iccc	Increase Decrease In Long Term Investments IncreaseDecreaseInLongTermInvestments	496000	USD
CY2014Q1	iccc	Increase Decrease In Cash And Cash Equivalents Short Term And Longterm Investments IncreaseDecreaseInCashAndCashEquivalentsShortTermAndLongtermInvestments	216346	USD
CY2014Q1	iccc	Amounts In Excess Of Fdic Limits AmountsInExcessOfFdicLimits	1739000	USD
CY2013Q4	iccc	Amounts In Excess Of Fdic Limits AmountsInExcessOfFdicLimits	1770000	USD

Files In Submission

Name	View Source	Status
0001144204-14-030195-index-headers.html	Edgar Link	pending
0001144204-14-030195-index.html	Edgar Link	pending
0001144204-14-030195.txt	Edgar Link	pending
0001144204-14-030195-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
iccc-20140331.xml	Edgar Link	completed
iccc-20140331.xsd	Edgar Link	pending
iccc-20140331_cal.xml	Edgar Link	unprocessable
iccc-20140331_def.xml	Edgar Link	unprocessable
iccc-20140331_lab.xml	Edgar Link	unprocessable
iccc-20140331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tpg16.jpg	Edgar Link	pending
v377964_10q.htm	Edgar Link	pending
v377964_ex31.htm	Edgar Link	pending
v377964_ex32.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ICCC
IMMUCELL CORP /DE/ Stock $iccc

2014 Q2 Form 10-Q Financial Statement

#000114420414030195 Filed on May 14, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICCC IMMUCELL CORP /DE/ Stock $iccc

2014 Q2 Form 10-Q Financial Statement

#000114420414030195 Filed on May 14, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICCC
IMMUCELL CORP /DE/ Stock $iccc